---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-010791"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2026-03-18T23:59:59+00:00"
generated_at: "2026-05-15T09:50:41.794002+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# InspireMD reports Q4 revenue $3.1M (+62% YoY); guides FY2026 rev $13-15M

## Summary
- Q4 revenue $3.1M, up 62% YoY; U.S. rev $0.9M (sequential +74%)
- Gross margin improved to 37.5% from 24.1% YoY; net loss $11.8M ($0.14/share)
- Full year 2025 rev $9.0M (+28% YoY); net loss $48.8M
- Cash and securities $54.2M at Dec 31, 2025 vs $34.6M year earlier
- FY2026 revenue guidance $13-15M (45-65% growth); PMA-S submitted for TCAR indication

## SEC filing metadata
- accession: 0001493152-26-010791
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2026-03-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010791/0001493152-26-010791-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010791/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-010791
- JSON: https://secwatch.observer/filing/0001493152-26-010791.json
- Plain text: https://secwatch.observer/filing/0001493152-26-010791.txt

## Key facts
- Earnings Releases
  InspireMD, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $3.1 million, net income $11.8 million or $0.14 per basic and diluted share.
  - Period: the fourth quarter ended December 31, 2025
  - Revenue: $3.1 million
  - Net income: $11.8 million or $0.14 per basic and diluted share
  - Result: reported results
  source text: of stroke, today announced financial and operating results for the fourth quarter and year ended December 31, 2025. Recent Business Highlights : ● Generated revenue of $3.1 million in the fourth quarter of 2025, up 62% year-over-year. ● Sustained strong commercial traction in the U.S. with the launch of CGuard Prime and continued growth in international
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010791/0001493152-26-010791-index.htm
- Earnings Releases
  InspireMD, Inc. reported the year ended December 31, 2025 results: revenue $9.0 million, net income $48.8 million or $0.76 per basic and diluted share. Guidance initiated.
  - Period: the year ended December 31, 2025
  - Revenue: $9.0 million
  - Net income: $48.8 million or $0.76 per basic and diluted share
  - Guidance: initiated
  - Result: reported results
  source text: $9.2 million or $0.19 per basic and diluted share, for the same period in 2024. Financial Results for the Year Ended December 31, 2025 For the full year 2025, total revenue was $9.0 million, representing an increase of 28%, as compared to $7.0 million during the full year 2024. U.S. revenue for the full year 2025 was $1.4 million, representing the first two quarters
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315226010791/0001493152-26-010791-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.